Logo

microfluidics

European 3DSecret Project to Deliver New Microfluidic Platform to Predict Cancer Metastasis
Premium

Sphere Fluidics is the sole commercial partner and has the right to commercialize any resulting technology.

After Series C Financing, Pattern Bioscience Preps Rapid AST System for Commercialization
Premium

The firm's platform combines single-cell microbiology and machine learning to deliver a result in four to six hours. 

Angle, BioView Partner to Develop Quantitative HER2 Assay Using Circulating Tumor Cells

The companies said recent developments in HER2-targeted therapies have created new commercial opportunities for a blood-based test.

Irish Diagnostics Firm Altratech Aims to Enter Molecular, POC Testing Space by Supplanting PCR
Premium

The Ireland-based firm said its inexpensive capacitance-based assays deliver "molecular detection by proxy," providing rapid, multiplex, quantitative results.

Fluxergy Acquires InnaMed's Blood Testing Tech to Support Metabolic Panel Development

Fluxergy said adding the electrochemical biosensor technology will expand the capabilities of its decentralized sample-to-answer platform.

Dec 16, 2022

KU Leuven-led Project Aims to Develop Mass PCR Testing Platform for Future Pandemics
Premium

Nov 18, 2022

UCLA Team Uses Magnets, Microfluidics to Create Handheld Molecular Dx System
Premium

Oct 13, 2022

Standard BioTools Partner Ascendas Genomics Gets Chinese Approval for MDx Systems

Aug 11, 2022

ScreenIn3D Platform Relies on Microfluidics, 3D Modeling to Monitor Cancer Treatment Efficacy
Premium

Jun 17, 2022

EUA in Hand, MicroGEM Aims to Grow Market for 30-Minute RT-PCR System
Premium

Jun 3, 2022

Hong Kong-Based Team Develops Rapid Microfluidic SARS-CoV-2 Antibody Test
Premium

May 11, 2022

Interpace Biosciences, Miroculus, Twist Bioscience Partner to Automate NGS Library Prep in Cancer Dx

Jan 13, 2022

Florida Atlantic University Wins $1.3M NIH Grant to Develop Sample-to-Answer HIV Self-Test

Oct 29, 2021

Qiagen, NeuMoDx Lose Patent Appeal in BD/HandyLab Dispute

Sep 27, 2021

TE Connectivity to Expand IVD Offerings With Acquisition of Companies

Aug 25, 2021

Single-Molecule Microfluidic ELISA Platform Holds Promise for Rapid Bedside Diagnostics
Premium

May 25, 2021

UCSC, BYU Team Developing 'Ultrasensitive' Optofluidic Antigen Test for SARS-CoV-2, Flu
Premium

May 20, 2021

With Finder Platform, Baebies Works to Expand Options for Neonatal Dx Testing
Premium

Apr 12, 2021

Singapore, MIT Researchers Develop Immune Response Test to Improve Infectious Disease Diagnosis
Premium

Mar 31, 2021

Biocept Prepares for First FDA Foray With CSF Liquid Biopsy Brain Metastases Assay
Premium

Mar 29, 2021

Biocept Q4 Revenues Spike as COVID-19 Testing Continues to Soar, Core Cancer Tests Lag

Feb 10, 2021

Fluidigm Q4 Revenues Grow 38 Percent on COVID-19-Driven Microfluidics Growth

Jan 25, 2021

Fluxergy Aiming to Provide Low-Cost, Multimodal Testing for SARS-CoV-2, Other Disease Targets
Premium

Dec 28, 2020

COVID-19 Pandemic Accelerated Development of CRISPR as a Diagnostic Platform in 2020

Dec 14, 2020

Imec Preparing Breath Test for SARS-CoV-2